The catchment area of Case Comprehensive Cancer Center (Case CCC) is the 15-county region in Northeast Ohio surrounding the City of Cleveland with a census of 4 million individuals, in which about 80% of the cancer patients seen at consortium hospitals reside. Of note, within this 15-county region, 62% of all cancer patients are seen at a consortium hospital site. Over the past 5 years, Case CCC has impacted the catchment area and beyond with thoughtful community-engaged research and outreach programs. The Center has recognized poverty as an important root cause of cancer disparities, and assembled a team of investigators, local government, and the safety-net provider network to engage communities for interventions on poverty and cancer prevention, and early detection services. The overarching goals of the Community Outreach and Engagement component are to build capacity for 1) collaborative, community-focused cancer research of relevance to the catchment area, and 2) outreach programs to increase cancer awareness and knowledge, and effective patient navigation.
Specific aims of the Community Outreach and Engagement component are to: 1. Implement population-based approaches to understand cancer burden in the catchment area and to guide scientific inquiry on distinct cancer-related challenges. 2. Use knowledge of the distinct cancer issues in the catchment area to stimulate new scientific discoveries, and disseminate findings into the population at large, including underserved communities. 3. Promote cancer disparities reduction and health equity through an inclusive research environment. The Case CCC is also addressing the high rates of lung cancer by strategically focusing on primary and tertiary prevention, including the implementation of a tobacco Quit Line eReferral system at the MetroHealth System, and providing data and testimony that were instrumental in passing the Tobacco 21 law in the city of Cleveland in 2015. Case CCC has established a Community Advisory Board (CAB) to guide catchment area research, and recently established the Office of Cancer Disparities Research (OCDR) to support, coordinate, and foster interdisciplinary cancer disparities research, training, and outreach program evaluation. Collectively, this program seeks to demonstrate the Case CCC?s commitment to working together to enhance the discovery process, promote innovative and community-changing collaborations, educate and motivate the citizens of Northeast Ohio and beyond, and conduct research across the Center?s Research Programs of direct relevance to the catchment area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA043703-28
Application #
9488779
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-10
Budget End
2019-03-31
Support Year
28
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Bosca, Federica; Bielecki, Peter A; Exner, Agata A et al. (2018) Porphyrin-Loaded Pluronic Nanobubbles: A New US-Activated Agent for Future Theranostic Applications. Bioconjug Chem 29:234-240
Benson, Bryan L; Li, Lucy; Myers, Jay T et al. (2018) Biomimetic post-capillary venule expansions for leukocyte adhesion studies. Sci Rep 8:9328
Morrow, James J; Bayles, Ian; Funnell, Alister P W et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med 24:176-185
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Anderson, Christian E; Wang, Charlie Y; Gu, Yuning et al. (2018) Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn Reson Med 79:2176-2182
Burger, Denis R; Parker, Yvonne; Guinta, Kathryn et al. (2018) PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice. Biol Blood Marrow Transplant 24:260-266
Shi, Xiaojun; Wang, Bingcheng (2018) Caught in the ""Akt"": Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF. Sci Signal 11:
Tartakoff, Alan Michael; Dulce, David; Landis, Elizabeth (2018) Delayed Encounter of Parental Genomes Can Lead to Aneuploidy in Saccharomyces cerevisiae. Genetics 208:139-151
Gromovsky, Anthony D; Schugar, Rebecca C; Brown, Amanda L et al. (2018) ?-5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators. Arterioscler Thromb Vasc Biol 38:218-231
Ignatz-Hoover, James J; Wang, Victoria; Mackowski, Nathan M et al. (2018) Aberrant GSK3? nuclear localization promotes AML growth and drug resistance. Blood Adv 2:2890-2903

Showing the most recent 10 out of 1227 publications